# Minor Use Minor Species Development of Drugs (R01)

This Notice of Funding Opportunity (NOFO) is issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), and solicits Research Project (R01) grant applications from institutions or organizations that propose to develop or support the development of designated new animal drugs intended for minor uses in major species or for use in minor species (MUMS). The FDA is authorized to provide grants to assist in defraying the costs of qualified safety and effectiveness testing that could be used to satisfy the requirements for FDA approval of MUMS-designated drugs. Only entities developing drugs for veterinary use or parties working as research partners with such entities...

Canonical page: https://grantsonar.com/grants/opportunity/minor-use-minor-species-development-of-drugs-r01-760d582b-9b80-4d19-a4c6-2cff69f7bc0f
Source: grants_gov
Source ID: 354573
Last confirmed Oct 13, 2026 · Grants.gov
Deadline: January 29, 2027
Award size: not disclosed

## Answer-first Q&A

### Who is eligible for Minor Use Minor Species Development of Drugs (R01)?

Minor Use Minor Species Development of Drugs (R01) eligibility includes eligible applicants named in the notice. Geographic eligibility is national or notice-specific geography; applicants should confirm the source notice before applying.

### What is the deadline for Minor Use Minor Species Development of Drugs (R01)?

Minor Use Minor Species Development of Drugs (R01) has a listed deadline of January 29, 2027. Grant deadlines can change, so verify the current date with Food and Drug Administration before submitting.

### How much funding is available for Minor Use Minor Species Development of Drugs (R01)?

Minor Use Minor Species Development of Drugs (R01) lists an award size of not disclosed. Award ranges and total program funding are reported from the source metadata when available.

### Who funds Minor Use Minor Species Development of Drugs (R01)?

Minor Use Minor Species Development of Drugs (R01) is funded by Food and Drug Administration. GrantSonar tracks the notice with source ID 354573 from grants_gov.